InsidersTradesSigma
Explore the full record of transactions filed by Auchincloss Thomas G, Director. Officer active across 1 companies, notably Concert Pharmaceuticals, INC.. Aggregated, 4 disclosures have been published. Total volume traded: €27k. The latest transaction was disclosed on 6 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations
Thomas G. Auchincloss is a Board Member at Concert Pharmaceuticals, Inc. He contributes to the strategic direction of the company, bringing his expertise in biotechnology and product development. His role is essential in supporting innovation and growth.